27th Asian Pacific Association for the Study of the Liver (APASL 2018) Hepatology-The Next Genre that will be held from March 14 to 18, 2018 in New Delhi, India..
It is a great pleasure for us to invite you to the 27th Asian Pacific Association for the Study of the Liver (APASL 2018) that will be held from March 14 to 18, 2018 in New Delhi, India.. We are delighted to welcome you to the cultural and historical metropolis of New Delhi.
The conference program will have high quality content with up-to-date information by eminent researchers and clinicians, covering all aspects of Hepatology.
The conference will provide an avenue for cooperation and collaboration amongst various institutions, academicia, companies, associations, non-profit organizations, and other related sectors, to deliver benefits to the people in the Asian Pacific region, where liver disease continues to be a major problem area.
This would be the perfect opportunity for all of us to share our views, values, experiences and practices regarding liver diseases, such as Viral Hepatitis, Liver Cancers, NASH, Liver Failure, Portal hypertension, Alcoholic Liver Disease, Liver Transplantation, Pediatric Liver Diseases, Liver Radiology, and other topics.
Abstracts must be submitted electronically via the conference website. No faxed or mailed abstracts will be accepted. There are no exceptions to the deadline as the review period ensues immediately after the submission site closes.
All presentations at APASL Annual Meeting 2018 will be in English.
Authors must select a submissions category when submitting their abstract. Please find the below Full List Of Abstract Submission Categories:
Acute Liver Failure and Artificial Liver Support-Clinical
CA-01 Acute Liver Failure and Artificial Liver Support-Clinical
Acute Liver Failure and Artificial Liver Support- Basic
BA-01 Acute Liver Failure and Artificial Liver Support-Basic Science
Alcoholic Liver Disease-Clinical
CAL-01 Alcoholic Liver Disease: Clinical and Therapeutic
Alcoholic Liver Disease-Basic
BAL-01 Alcoholic Liver Disease: Experimental
Hepatitis B and D-Clinical
CB-01 Diagnostics, Epidemiology, Prevention, Natural History
CB-02 Therapeutics: New and Approved
Hepatitis B and D-Basic
BB-01 Virology, Pathogenesis, and Immunology
Biliary and pancreatic Neoplasia other than Liver cancer-Clinical
CBN-01 Diagnostics and Liver Imaging of biliary and pancreatic neoplasia
CBN-02 Prognosis : biliary and pancreatic neoplasia
CBN-03 Surgery and Loco-Regional Therapy for biliary and pancreatic neoplasia
CBN-04 Targetted and systemic therapies for biliary and pancreatic neoplasia
Biliary and pancreatic Neoplasia other than Liver cancer-Basic
BBN-01 Experimental carcinogenesis of biliary and pancreatic neoplasia
CC-01 Diagnostics, Epidemiology, Natural History
CC-02 Therapeutics: Preclinical and Early Clinical Development
CC-03 Therapeutics: New Agents (not approved, phase 2-3)
CC-04 Therapeutics: Approved Agents
BC-01 Virology, Pathogenesis, and Immunology
Cholestatic and Autoimmune Liver Diseases-Clinical
CCA-01 PBC/PSC and Other Cholestatic Disease: Clinical and Therapeutics
CCA-02 Autoimmune Liver Disease: Clinical and Therapeutics
Cholestatic and Autoimmune Liver Diseases-Basic
BCA-01 Transport, Bilirubin, Cholesterol, Lipids and Bile Salts, Cholangiocyte Biology and Experimental Cholestasis
BCA-02 Autoimmune Liver Disease:Experimental
Drug Induced Liver Injury-Clinical
CD-01 Predictors of Drug Toxicity and Therapy
Drug Induced Liver Injury-Basic
BD-01 Pathogenesis and Mechanisms
BD-02 Drug Metabolism, and Toxicity
Hepatitis A and E-Clinical
CE-01 Hepatitis A and E- Clinical and Therapeutic
Hepatitis A and E-Basic
BE-01 Hepatitis A and Experimental
Liver Fibrogenesis and Non-Parenchymal Cell Biology-Clinical
BF-01 Imaging and Noninvasive Markers of Liver Fibrosis
BF-02 Clinical and Translational Fibrosis Research and Therapy
Liver Fibrogenesis and Non-Parenchymal Cell Biology-Basic
BF-01 Basic Fibrosis Research and Stellate Cell Biology
Genetic and Metabolic Disease-Clinical
CG-01 Hemochromatosis, Wilson Disease, ?-1 Antitrypsin Deficiency-Clinical
CG-02 Other genetic and metabolic disorders-Clinical
Genetic and Metabolic Disease-Basic
BG-01 Hemochromatosis, Wilson Disease, ?-1 Antitrypsin Deficiency-Experimental
BG-02 Other genetic and metabolic disorders-Experimental
There is a limit of 300 characters, including spaces, for the title of an abstract.
Please list all authors with their affiliations (institution, city and country).
Credit for authorship requires substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.
There is a limit of 3000 characters, including spaces, for the body of abstract submissions. Abstract titles, author names, author institutions, and information in tables and images do not count toward the 3000 character limit. Abstract text for original article should include 1) background/aims, 2) methods, 3) results and 4) conclusions. For case report, it should include introduction and case description. Do not include references and key words in the abstract.
Tables and Figures
A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 2M. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract.
Use the abbreviation in parentheses after the full word the first time it appears.
To avoid character corruption, please use only Times New Roman font.
Font size should be 10.
Editing A Submitted Abstract
Authors may edit submitted abstracts until the submissions deadline. Abstract submitters should log into their registration account to make any edits.
Institute of Liver and Biliary Sciences
D-1 Vasant Kunj, New Delhi - 110070, India
Dr. Barjesh C Sharma
Dr. Manoj K Sharma
Dr. Rakhi Maiwall
View Conference (Event Website) Details